Cingulate Inc. (CING): Total Assets
$15.07M
As of 2025-12-31
$33.07M
As of 2026-06-30
+9.7%
3-year compound annual growth
+21.1%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $15.07M | +1.4% | 2026-03-18, Balance as of period end |
| 2024-12-31 | $14.86M | +325.7% | 2026-03-18, Balance as of period end |
| 2023-12-31 | $3.49M | -69.4% | 2025-03-27, Balance as of period end |
| 2022-12-31 | $11.41M | -50.2% | 2024-04-01, Balance as of period end |
| 2021-12-31 | $22.89M | +295.4% | 2023-03-10, Balance as of period end |
| 2020-12-31 | $5.79M | n/a | 2022-03-28, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Cingulate Inc. (CING) | 2025-12-31 | $15.07M | +1.4% |
| Cellectar Biosciences, Inc. (CLRB) | 2025-12-31 | $14.98M | -41.2% |
| Synlogic, Inc. (SYBX) | 2025-12-31 | $15.45M | -22.1% |
| Reviva Pharmaceuticals Holdings, Inc. (RVPH) | 2025-12-31 | $15.92M | +2.7% |
| Aprea Therapeutics, Inc. (APRE) | 2025-12-31 | $15.93M | -33.6% |
| Biovie Inc. (BIVI) | 2026-06-30 | $14.25M | -33.9% |
| Anixa Biosciences Inc (ANIX) | 2025-10-31 | $16.08M | -25.5% |
| Exicure, Inc. (XCUR) | 2025-12-31 | $14.04M | -6.7% |
| Actuate Therapeutics, Inc. (ACTU) | 2025-12-31 | $14.04M | +50.6% |
Compare CING, CLRB, SYBX, RVPH side by side · Screen every company in Pharmaceutical Preparations ↗